AbCellera Biologics Inc.
ABCL- 交易所
- Nasdaq
- 產業
- Pharmaceutical Preparations
- SEC CIK
- 0001703057
近 90 天，AbCellera Biologics Inc. 內部人申報 3 筆公開市場買進、0 筆賣出；2026 年第 2 季末有 152 家機構在 13F 申報持有，市值合計 $9.09 億；沒有大師持有。
SEC 申報
AbCellera Biologics Inc. 向 SEC 申報的 10-K、10-Q、8-K、20-F、40-F，最新的在前。
Livermore 只列出每份申報的表單、8-K 的 Item 與日期。內文請到 SEC 網站讀；8-K 的新聞稿等附件（例如 Item 2.02 的 EX-99.1）在申報目錄裡。
| 申報日 | 表單 | 8-K 的 Item | 期間 | 原文 | 申報目錄 |
|---|---|---|---|---|---|
| 2026/11/9 | 10-Q | – | 2026/9/30 | SEC | 目錄 |
| 2026/11/9 | 8-K | 2.027.019.01 | 2026/11/9 | SEC | 目錄 |
| 2026/8/13 | 8-K | 1.018.019.01 | 2026/8/12 | SEC | 目錄 |
| 2026/8/10 | 8-K | 7.019.01 | 2026/8/10 | SEC | 目錄 |
| 2026/8/7 | 8-K | 8.019.01 | 2026/8/7 | SEC | 目錄 |
| 2026/8/5 | 10-Q | – | 2026/6/30 | SEC | 目錄 |
| 2026/8/5 | 8-K | 2.027.019.01 | 2026/8/5 | SEC | 目錄 |
| 2026/7/29 | 8-K | 8.019.01 | 2026/7/29 | SEC | 目錄 |
| 2026/7/6 | 8-K | 5.029.01 | 2026/6/30 | SEC | 目錄 |
| 2026/6/17 | 8-K | 8.019.01 | 2026/6/17 | SEC | 目錄 |
| 2026/6/12 | 8-K | 5.07 | 2026/6/11 | SEC | 目錄 |
| 2026/6/5 | 8-K | 5.029.01 | 2026/6/1 | SEC | 目錄 |
| 2026/5/11 | 10-Q | – | 2026/3/31 | SEC | 目錄 |
| 2026/5/11 | 8-K | 2.027.019.01 | 2026/5/11 | SEC | 目錄 |
| 2026/2/24 | 10-K | – | 2025/12/31 | SEC | 目錄 |
| 2026/2/24 | 8-K | 2.027.019.01 | 2026/2/24 | SEC | 目錄 |
| 2026/1/14 | 8-K | 7.019.01 | 2026/1/12 | SEC | 目錄 |
| 2025/12/18 | 8-K | 7.019.01 | 2025/12/18 | SEC | 目錄 |
| 2025/11/28 | 8-K | 4.019.01 | 2025/11/24 | SEC | 目錄 |
| 2025/11/12 | 8-K | 5.029.01 | 2025/11/10 | SEC | 目錄 |
| 2025/11/6 | 10-Q | – | 2025/9/30 | SEC | 目錄 |
| 2025/11/6 | 8-K | 2.027.019.01 | 2025/11/6 | SEC | 目錄 |
| 2025/9/10 | 8-K | 8.019.01 | 2025/9/10 | SEC | 目錄 |
| 2025/8/7 | 10-Q | – | 2025/6/30 | SEC | 目錄 |
| 2025/8/7 | 8-K | 2.027.019.01 | 2025/8/7 | SEC | 目錄 |
| 2025/6/13 | 8-K | 5.07 | 2025/6/12 | SEC | 目錄 |
| 2025/5/30 | 8-K | 8.019.01 | 2025/5/30 | SEC | 目錄 |
| 2025/5/14 | 8-K | 8.019.01 | 2025/5/14 | SEC | 目錄 |
| 2025/5/13 | 8-K | 8.019.01 | 2025/5/12 | SEC | 目錄 |
| 2025/5/8 | 10-Q | – | 2025/3/31 | SEC | 目錄 |
| 2025/5/8 | 8-K | 2.027.019.01 | 2025/5/8 | SEC | 目錄 |
| 2025/2/27 | 10-K | – | 2024/12/31 | SEC | 目錄 |
| 2025/2/27 | 8-K | 2.027.019.01 | 2025/2/27 | SEC | 目錄 |
| 2025/2/18 | 8-K | 8.01 | 2025/2/18 | SEC | 目錄 |
| 2024/11/4 | 10-Q | – | 2024/9/30 | SEC | 目錄 |
| 2024/11/4 | 8-K | 2.027.019.01 | 2024/11/4 | SEC | 目錄 |
| 2024/8/6 | 10-Q | – | 2024/6/30 | SEC | 目錄 |
| 2024/8/6 | 8-K | 2.027.019.01 | 2024/8/6 | SEC | 目錄 |
| 2024/6/13 | 8-K | 5.07 | 2024/6/13 | SEC | 目錄 |
| 2024/5/7 | 10-Q | – | 2024/3/31 | SEC | 目錄 |
| 2024/5/7 | 8-K | 2.027.019.01 | 2024/5/7 | SEC | 目錄 |
| 2024/2/23 | 8-K | 5.029.01 | 2024/2/16 | SEC | 目錄 |
| 2024/2/20 | 10-K | – | 2023/12/31 | SEC | 目錄 |
| 2024/2/20 | 8-K | 2.027.019.01 | 2024/2/20 | SEC | 目錄 |
| 2023/11/28 | 8-K | 8.01 | 2023/11/28 | SEC | 目錄 |
| 2023/11/2 | 10-Q | – | 2023/9/30 | SEC | 目錄 |
| 2023/11/2 | 8-K | 2.027.019.01 | 2023/11/2 | SEC | 目錄 |
| 2023/10/13 | 8-K | 8.01 | 2023/9/18 | SEC | 目錄 |
| 2023/8/3 | 10-Q | – | 2023/6/30 | SEC | 目錄 |
| 2023/8/3 | 8-K | 2.027.019.01 | 2023/8/3 | SEC | 目錄 |